Northwire Canada EditionThursday, July 16, 2026
Northwire
CLCH 1.17 −4.1% DG 0.035 +0.0% SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6% CLCH 1.17 −4.1% DG 0.035 +0.0% SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6%
Financings

TempraMed Launches New Product, VIVI Cap Smart, Expanding Its Portfolio to Include a Digital Health Offering

VIVI · Price

Executive Summary

  • TempraMed Technologies Ltd. launched VIVI Cap Smart, an upgraded version of its VIVI Cap that adds digital health functionality and a temperature‑shield for insulin and GLP‑1 pens.
  • The new device introduces a subscription‑based revenue model via an optional connected mobile application that records injection timing, dose information, and enables data sharing with caregivers and healthcare providers.
  • Launch represents a strategic step toward TempraMed’s broader “whole‑patient” platform, combining its patented passive temperature‑protection technology with digital tools to improve medication adherence and generate recurring revenue.

Key Details

  • Product Features
  • Passive, power‑free temperature protection for insulin/GLP‑1 pens (24/7).
  • Integrated injection‑timing display showing elapsed time since last dose.
  • Optional connected mobile app that logs injection times, user‑entered dose data, and stores a digital logbook.
  • Data export capability for sharing with caregivers, healthcare providers, and corporate health programs.

  • Business Model Expansion

  • Introduction of a subscription‑based model (monthly fees) tied to the mobile application.
  • Recurring revenue expected from existing customer base and new adopters seeking digital adherence tools.

  • Strategic Significance

  • Marks TempraMed’s transition toward a “whole‑patient” platform that blends physical device innovation with digital health services.
  • Positions the company to capture pharma, healthcare provider, and real‑time data opportunities related to medication compliance, efficacy, and side‑effect monitoring.

  • Executive Quote

  • “We are excited to launch the commercial availability of VIVI Cap Smart… This reflects our broader strategy to deliver practical, user‑centered solutions that ease the burden of long‑term care.” – Ron Nagar, CEO, TempraMed

Notable Quotes

  • Ron Nagar, Chief Executive Officer: “Living with a chronic condition requires constant attention and decision‑making… With VIVI Cap Smart, we are extending our proprietary technology to address not only medication protection, but also the everyday challenges of remembering and managing important injections.”
Read the original news release →

More from TempraMed Technologies Ltd.